US Inflammatory Bowel Disease (IBD) Market Industry Analysis, Growth, Trends and Forecast 2019-2025

The US IBD market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. factors such as the significant prevalence of IBD such as Crohn's disease and ulcerative colitis across the country. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn's disease and ulcerative colitis in the US was 201 and 238 per 100,000 populations respectively in 2015. Moreover, the CDC also estimates the incidence rate of types of IBD across the country. As per the CDC, the incidence of Crohn's disease and ulcerative colitis were nearly 14.6 and 14.3 per 100,000 populations respectively in 2015. Additionally, according to the aforementioned organization, the percentage of people diagnosed with IBD (either Crohn's disease or ulcerative colitis) increased from 0.9% of US adults in 1999 to 1.3% of US adults in 2015. This percentage is further expected to expand in the near future; thereby, promising significant growth for the IBD market during the forecast period.

Get Sample Copy of US Inflammatory Bowel Disease (IBD) Market at: https://www.omrglobal.com/request-sample/us-ibd-inflammatory-bowel-disease-market

The companies which are contributing to the growth of the US IBD market include Abbott Laboratories, AbbVie Inc., Accesa Labs, Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Laboratory Corporation of America Holdings, Pfizer Inc., and others.

US IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. US IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn's disease. Crohn's disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn's disease than ulcerative colitis. On the basis of diagnostics, the market segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti-inflammatory drugs and surgery.

For More Information, get A full report of US Inflammatory Bowel Disease (IBD) Market is available at: https://www.omrglobal.com/industry-reports/us-ibd-inflammatory-bowel-disease-market

There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressant's (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

Market Segmentation

IBD Market by Disease Type

o Ulcerative Colitis
o Crohn's Disease

IBD Market by Diagnostics

o Blood and Stool Tests
o Endoscopies,
o Ultrasound
o X-Ray

IBD Market by Therapeutics

o Surgery
o Anti- Inflammatory Drug Administration
o Steroids
o Immunosuppressant
o Biological Drugs
o Amino salicylates
o Others

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/us-ibd-inflammatory-bowel-disease-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.